Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.
Journal: Journal of clinical psychopharmacology
Published: March 31, 2018
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 18, 2017
Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Journal: Journal of psychiatric research
Published: July 01, 2016
Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.
Journal: Biological psychiatry
Published: February 23, 2016
Novel Glutamatergic Treatments for Severe Mood Disorders.
Journal: Current behavioral neuroscience reports
Published: January 30, 2016
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder.
Journal: Current neuropharmacology
Published: August 06, 2015
Showing 1-6 of 6
Last Updated: 09/26/2026